Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Leap Therapeutics, Inc.
Jan 23, 2020
Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting
Jan 07, 2020
Leap Therapeutics Announces Closing of Previously Announced Equity Financing
Jan 03, 2020
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
Nov 14, 2019
Leap Therapeutics Reports Third Quarter 2019 Financial Results
Aug 09, 2019
Leap Therapeutics Reports Second Quarter 2019 Financial Results
Aug 06, 2019
Leap Presents Positive Clinical Results for the Combination of DKN-01 plus Keytruda® and Provides DKN-01 Program Update
Jul 25, 2019
Leap Therapeutics to Host Conference Call to Provide DKN-01 Program Update
Jun 11, 2019
Leap Therapeutics to Present at the 2019 Raymond James Life Sciences and MedTech Conference
Apr 01, 2019
Leap Therapeutics Reports Clinical Update and 2018 Financial Results
Mar 18, 2019
Leap Therapeutics Presents at Society of Gynecologic Oncology 50th Annual Meeting on Women's Cancer
Mar 08, 2019
Leap Therapeutics to Present at the Society of Gynecologic Oncology 2019 Annual Meeting on Women's Cancer
Jan 31, 2019
Leap Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
Jan 14, 2019
Leap Therapeutics Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer
Nov 09, 2018
Leap Therapeutics Reports Third Quarter 2018 Business Update and Financial Results
Oct 08, 2018
Leap Therapeutics to Present Data from Study Evaluating DKN-01 in Combination with KEYTRUDA® (pembrolizumab) at the European Society of Medical Oncology 2018 Congress
‹‹
Page 2
Latest News
Mar 28, 2024
EIG’s MidOcean Energy Completes Acquisition of Tokyo Gas’ Interests in Portfolio of Australian Integrated LNG...
Mar 28, 2024
Durability of Sandton (RSA) Water Reservoir Provided by the Penetron System
Mar 28, 2024
Amish Patel Joins Sierra Space as Chief Operating Officer
Mar 28, 2024
Fincantieri: contract signed for the supply of two PPAs to Indonesia
Mar 28, 2024
Toshiba Launches SmartMCD™ Series Gate Driver ICs with Embedded Microcontroller
Mar 28, 2024
Liberty Energy Inc. Announces Timing of Release of First Quarter 2024 Financial Results and Conference Call
Mar 28, 2024
SLB Announces Agreement to Acquire Majority Ownership in Aker Carbon Capture
Mar 28, 2024
Fisker Announces Reduced MSRP in U.S. on Many 2023 Model Year Vehicles
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events